DossierENTITY

Tumor-infiltrating lymphocyte therapy

Coverage of Tumor-infiltrating lymphocyte therapy in the Nexus archive.

Earliest in view: Aug 3 · 01:13 UTCMost recent: Aug 3 · 01:13 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHAug 3 · 01:13 UTCCBS NEWS
New treatment for advanced melanoma uses tumor to fight the disease
The FDA has approved a new treatment for advanced melanoma called Tumor-infiltrating lymphocyte (TIL) therapy, which uses a patient's own tumor to combat the disease. The treatment is reported by CBS News' Natalie Brand.